Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1500 of 3284 entries
View as:

Asthma Control Study 2011

Phase: N/A Priority: Normal
NCT ID: NCT01298739 Org: User:
Start: 02/28/11 End: 10/31/11 Due: 10/31/12

Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00501605 Org: User:
Start: 02/28/03 End: 02/28/06 Due: 02/28/07

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01144338 Org: User:
Start: 06/18/10 End: 04/24/17 Due: 04/24/18

This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01030224 Org: User:
Start: 11/30/09 End: 03/31/10 Due: 03/31/11

Esomeprazole in PPI Failures - IMPROVE

Phase: N/A Priority: Normal
NCT ID: NCT00272701 Org: User:
Start: 12/31/05 End: 02/28/07 Due: 02/28/08

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03778957 Org: User:
Start: 11/30/18 End: 08/31/26 Due: 08/31/27

A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT03019549 Org: User:
Start: 01/12/17 End: 05/22/17 Due: 05/22/18

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.

Phase: N/A Priority: Normal
NCT ID: NCT03528681 Org: User:
Start: 05/06/21 End: 09/15/22 Due: 09/15/23

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02243176 Org: User:
Start: 09/30/14 End: 09/30/15 Due: 09/30/16

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT02036645 Org: User:
Start: 02/04/14 End: 09/15/16 Due: 09/15/17

Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01358383 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01662999 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13

A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin

Phase: N/A Priority: Normal
NCT ID: NCT01199341 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

Phase: N/A Priority: Normal
NCT ID: NCT02321046 Org: User:
Start: 09/02/15 End: 06/28/19 Due: 06/28/20

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

Phase: N/A Priority: Normal
NCT ID: NCT03619213 Org: User:
Start: 08/27/18 End: 03/27/22 Due: 03/27/23

Seroquel in Bipolar Depression Versus Lithium

Phase: N/A Priority: Normal
NCT ID: NCT00206141 Org: User:
Start: 08/31/05 End: 05/31/07 Due: 05/31/08

Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199

Phase: N/A Priority: Normal
NCT ID: NCT00736489 Org: User:
Start: 08/31/08 End: 12/31/08 Due: 12/31/09

CP-675,206 In Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00086489 Org: User:
Start: 08/31/03 End: 05/31/09 Due: 05/31/10

A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05847140 Org: User:
Start: 06/27/22 End: 01/31/24 Due: 01/31/25

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

Phase: N/A Priority: Normal
NCT ID: NCT00348686 Org: User:
Start: 06/30/06 End: 06/30/08 Due: 06/30/09

Adults With Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00642122 Org: User:
Start: 04/30/03 End: 12/31/04 Due: 12/31/05

Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00515866 Org: User:
Start: 08/31/07 End: 07/31/12 Due: 07/31/13

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00554229 Org: User:
Start: 11/30/07 End: 08/31/11 Due: 08/31/12

Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.

Phase: N/A Priority: Normal
NCT ID: NCT01244646 Org: User:
Start: 12/31/10 End: 08/31/12 Due: 08/31/13

Symptom Adapted Therapy in GERD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00343161 Org: User:
Start: 08/31/06 End: 08/31/07 Due: 08/31/08